skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

115 Total results for product and free and sample content found


Meddevicetracker weekly round up 20th February

27 Feb 2017

Meddevicetracker Weekly News Write-Up February 20-24, 2017

Topic Medtech Medtech weekly roundup


Pharma's Orphan Drug Activity Infographic

27 Feb 2017

More than two-fifths of new drugs approved in the US last year were orphan drugs, and there are more than 4,500 drugs in active development for rare diseases. Effective orphan drug legislation and incentivization programs introduced gradually around the world since the 1980s mean rare diseases are no longer a rare sighting in the pharma industry pipeline, as this infographic illustrates.

Topic Rare Disease

Pink Sheet

Generic Industry Hit With Avalanche Of Price Fixing Suits

By Brenda Sandburg 23 Feb 2017

As state attorneys general and Department of Justice move against generic manufacturers, plaintiffs’ firms have filed more than 90 antitrust suits.

Topic BioPharmaceutical Policy and regulation

Clinical and Research Excellence

CARE Awards Shortlist 2017

23 Feb 2017

We are delighted to announce the finalists for the 2017 Clinical and Research Excellence Awards.

Topic Clinical trials blog Clinical trials


Bayer Bets On Oncology Pipeline Vows To Increase 2017 R&D Budget

By Lucie Ellis 22 Feb 2017

Bayer has launched an internal oncology R&D unit to speed up development of its pipeline cancer therapies and ensure the company is first to market with its late-stage treatment candidates, head of pharma Dieter Weinand told Scrip on the sidelines of the pharma's annual results conference.

Topic Cancer Research

In Vivo

Cystic Fibrosis: Successes, Opportunities And Challenges

By Lucie Ellis 22 Feb 2017

What is next for the treatment of cystic fibrosis, a rare disease market that has boomed in recent years on the back of new drug approvals with hefty price tags? Pipelines are full, but securing reimbursement is a challenge.

Topic Clinical trials


Five Big Picture R&D Questions For J&J’s

By Anju Ghangurde 14 Feb 2017

Five Big Picture R&D Questions For J&J’s Stoffels, Novartis’s Narasimhan

Topic Research Company analysis


Where There's A Cure There's Controversy: Raymond Schinazi's Storyarticle 2

By Jo Shorthouse 14 Feb 2017

Where There's A Cure There's Controversy: Raymond Schinazi's Story

Topic Research

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: